Stem cells can tailor their role in gene therapy based on the underlying disease, study suggests
RCCS San Raffaele Scientific Institute in Milan researchers have discovered that hematopoietic stem cells (HSCs) adapt their lineage commitment during gene therapy based on the underlying genetic ...
Fred Hutch29d
Cell & Gene Therapy
Our research on cell-based therapies also includes cutting-edge immunotherapies ... The device may help pave the way toward making gene therapy accessible and affordable beyond a handful of ...
EurekAlert!19d
$1.8 million awarded to study the durability of gene therapy
The ultimate goal is to enable improved design of gene therapy approaches with the aim of life-long correction across a range ...
The American Journal of Managed Care23d
CNS-Directed AAV Gene Therapy: Immune Dynamics and Clinical Implications
CNS-directed AAV gene therapy shows milder immune responses compared to systemic ... via IP delivery exhibited minimal changes in B-cell responses, regardless of baseline anti-AAV titers or ...
University of Pennsylvania gene therapy spinout Interius BioTherapeutics doses patient, achieves CAR therapy first
Its lead gene therapy candidate has the potential to be faster, less expensive, and more widely available than current CAR T ...
Disrupting Asxl1 gene prevents T-cell exhaustion to improve immunotherapy, researchers discover
"We discovered that disrupting the Axsl1 gene in T cells resulted in a better response to immune checkpoint blockade ...
Labroots24d
Cell & Gene Therapy Virtual Event Series 2024
Expect in-depth discussions covering revolutionary technologies used for precision genome editing, advancements and innovations in immune effector cell therapies, and the growing role or AI in gene ...
Business Insider3d
Genprex to present positive preclinical data from Reqorsa Gene Therapy study
Genprex (GNPX) announced that its research collaborators at Meharry Medical College will present a poster detailing positive preclinical data from a study of the Company’s lead drug candidate, Reqorsa ...
Baylor College of Medicine3d
Grants awarded to leading investigators at Baylor's Center for Cell and Gene Therapy
Three investigators at Baylor College of Medicine’s (BCM) Center for Cell and Gene Therapy Institute (CAGT ... Grant to develop innovative gene editing platforms to create potent immune cell therapies ...
Becker's Hospital Review18d
1st sickle cell gene therapy patient completes treatment
Kendric Cromer began treatment with Bluebird bio's sickle cell gene therapy in May ... childhood vaccinations and avoid crowds while his immune system remains compromised, but he is expected ...
Genprex Collaborators Present Positive Preclinical Data on Reqorsa® Gene Therapy at the Society for Immunotherapy of Cancer 2024 Annual Meeting
Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing life-changing therapies for patients with cancer and diabetes, today announced ...
Science Daily1mon
Disrupting Asxl1 gene prevents T-cell exhaustion, improving immunotherapy
Disrupting the Asxl1 gene in T cells enhanced response to immune checkpoint blockade and ... of Bone Marrow Transplantation and Cellular Therapy. T cells that encounter too many tumor cell pieces ...